SCHEMBL933702

SCHEMBL933702

Cc1ccc(SCC(=O)Nc2ccc(Cl)cn2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.76
▸ RAB9A P51151 3/20 0.66
▸ TP53 P04637 2/20 0.63
▸ TSHR P16473 2/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ LMNA P02545 1/20 0.63
▸ AHR P35869 1/20 0.62
▸ KMT2A Q03164 4/20 0.60
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ POLB P06746 1/20 0.60
▸ NFKB1 P19838 1/20 0.59
▸ NFKB2 Q00653 1/20 0.59
▸ RELA Q04206 1/20 0.59
▸ MAPT P10636 2/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ PTPN5 P54829 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11887682 0.78 AHR (0.67) GAALMNAAHRKMT2AALDH1A1
SCHEMBL23262624 0.77 CCNK (0.74) GAAAHRKMT2AMEN1MAPT
SCHEMBL31681811 0.77 CCNK (0.74) GAAAHRKMT2AMEN1MAPT
SCHEMBL19090370 0.75 TDP1 (0.73) RAB9ATP53TSHRLMNASMN1; SMN2
SCHEMBL11888631 0.75 KMT2A (1.00) GAAHSD17B10AHRKMT2ASMN1; SMN2
SCHEMBL23933096 0.74 TDP1 (1.00) GAARAB9ATP53TSHRLMNA
SCHEMBL12035866 0.74 RAB9A (0.59) GAARAB9ATSHRLMNAAHR
SCHEMBL2188598 0.74 TDP1 (0.71) RAB9ATP53TSHRLMNASMN1; SMN2
SCHEMBL2944497 0.74 TDP1 (0.71) RAB9ATP53TSHRLMNASMN1; SMN2
SCHEMBL29883158 0.74 TDP1 (0.71) RAB9ATP53TSHRLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011008475-A1 OPTIONALLY SUBSTITUTED 2-(ARYLMETHYL, ARYLOXY OR ARYLTHIO) -N- PYRIDIN-2 -YL-ARYL ACETAMIDE OR 2, 2-BIS (ARYL) -N-PYRIDIN-2-YL ACETAMIDE COMPOUNDS AS MEDICAMENTS FOR THE TREATMENT OF EYE DISEASES ALLERGAN, INC. (US) 2011-01-20 — — WO claimed
Send feedback